BTIG cuts ServiceNow stock price target on guidance concerns By Investing.com

BTIG cut ServiceNow's price target to $150 from $185 while keeping a Buy rating, citing slipped Middle East on-premise deals, expected margin pressure from the Armis integration, and a roughly $21 million reduction in fiscal 2026 organic subscription revenue expectations. The firm said second-quarter organic cRPO growth guidance of about 18% excluding M&A missed the 18.9% consensus, though ServiceNow said AI ACV is on track to exceed $1.5 billion this year and gross margins remain strong at 77.5%. The stock has fallen 45% over the past six months to $103.07, reflecting cautious investor sentiment despite continued revenue growth.

Analysis

The market is treating this as a multiple reset, but the bigger issue is credibility of near-term billings acceleration: when management starts layering in inorganic revenue while organic guidance quietly steps down, investors tend to mark down the quality of the growth algorithm, not just the headline growth rate. That matters for NOW because the stock has historically traded on the scarcity premium of durable enterprise software growth; once that premium compresses, the name can de-rate faster than the underlying fundamentals deteriorate.

Second-order, the integration mix is the real battleground. If Armis and adjacent acquisitions are used to repackage the platform into security/data/AI workflows, the long-run monetization opportunity is larger, but in the next 2-3 quarters it likely dilutes margin optics and makes subscription growth harder to read. The near-term loser here is not just NOW holders; it is also the high-multiple enterprise software cohort that trades on “quality growth” comparables, because any sign that AI attach is not immediately flowing through to core subscription acceleration will pressure the entire basket.

The contrarian setup is that the selloff may already be discounting too much of the bad news, especially if the analyst day gives a cleaner bridge between AI ACV and eventual revenue conversion. If management can show that AI deals are shortening sales cycles or expanding deal size rather than just inflating pipeline headlines, the market may re-rate the stock from a guidance story back to a platform story. The key timing catalyst is the May 4 analyst day; before then, the tape likely stays hostage to estimate cuts and skepticism.

Tail risk is that the company has effectively entered a two-quarter “prove it” window where any further slip in organic cRPO or integration drag will force another leg lower in consensus. Conversely, if the Middle East delays are genuinely one-off and close over the next 60-90 days, the current drawdown could be overdone because the base business still compounds at a premium rate versus software peers.

Key Decisions for Investors

• Buy NOW only as a tactical event trade ahead of May 4 analyst day; target a 10-15% rebound if management tightens the organic growth bridge, with a hard stop below the recent low because a second guidance miss would likely trigger another 15-20% down-leg.
• Use a pair trade: long NOW / short a basket of high-multiple enterprise software names most exposed to guidance credibility risk, sized for 3-6 weeks into analyst day. The setup works if the market keeps punishing any company with opaque AI monetization.
• If already long NOW, monetize the volatility by selling covered calls into the event; implied upside is likely capped until visibility improves, while downside remains open-ended if estimates are cut again.
• For more defensive exposure, wait for post-analyst-day confirmation before adding size; if the company shows stable organic cRPO and cleaner AI conversion, a 6-12 month mean reversion trade becomes attractive off a heavily compressed multiple.